Kolexia
Masset Christophe
Néphrologie
Hôpital Hôtel-Dieu Nantes
Nantes, France
108 Activités
153 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Thrombose Complications postopératoires Récidive tumorale locale Vascularite Diabète Maladies du rein Néphrite Maladies virales

Industries

Sanofi
5 collaboration(s)
Dernière en 2023
EXAFIELD
3 collaboration(s)
Dernière en 2022
Zeste Research
2 collaboration(s)
Dernière en 2021
IQVIA
2 collaboration(s)
Dernière en 2021

Dernières activités

KTOL: Non-interventional Single-center Study of the Contribution of DP8α Regulatory T Cells Induced by a Gut Microbiota Bacterium to Kidney Transplant Tolerance.
Essai Clinique (CHU Nantes)   20 mars 2024
Questions about the BEST-Fluids trial.
Lancet (London, England)   09 mars 2024
Primary Graft Function and 5 Year Insulin Independence After Pancreas and Islet Transplantation for Type 1 Diabetes: A Retrospective Parallel Cohort Study.
Transplant international : official journal of the European Society for Organ Transplantation   28 décembre 2023
Dialysis catheter-related bloodstream infections in the early post-transplant period: lessons for the clinical nephrologist.
Journal of nephrology   06 novembre 2023
Evolution of anti-spike responses to SARS-CoV-2 vaccination within 6 months post-transplantation in patients previously vaccinated while on the transplant waiting list.
Clinical transplantation   02 septembre 2023
WBC and Platelet Evolution After Pancreas Transplantation Suggests 2 Phenotypes of Allograft Thrombosis.
Transplantation   28 août 2023
Sterile Pancreas Inflammation during Preservation and after Transplantation.
International journal of molecular sciences   27 février 2023
Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients.
Transplant international : official journal of the European Society for Organ Transplantation   03 février 2023
Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patients.
Frontiers in immunology   28 novembre 2022
Effector Memory-Expressing CD45RA (TEMRA) CD8 T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor-Dependent Proinflammatory and Migratory Responses.
Journal of the American Society of Nephrology : JASN   24 octobre 2022